Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer modelsPeng Xia, Jing Ai|Journal of Experimental & Clinical Cancer Research|2019Cited by 32
DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivoMengdi Dai, Jing Ai|Acta Pharmacologica Sinica|2020Cited by 10